Non-Traditional Genetic Test for Childhood Cancers Improves Diagnosis & Treatment
Analysis of the entire tumor RNA picks up more clinically relevant genetic changes in children with cancer than traditional diagnostic methods.
Read MorePosted by Andy Lundin | Feb 8, 2022 | Cancer |
Analysis of the entire tumor RNA picks up more clinically relevant genetic changes in children with cancer than traditional diagnostic methods.
Read MorePosted by Andy Lundin | Feb 8, 2022 | Leukemia |
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.
Read MorePosted by Andy Lundin | Dec 28, 2021 | Cancer, Sequencing Systems |
NeoGenomics will use Thermo Fisher Scientific’s next-generation sequencing solution in a pharma-sponsored Phase 1 study of myeloid cancer.
Read MorePosted by Toni Mitchell | Sep 21, 2021 | Leukemia, Microbiology Instruments, Prenatal Testing |
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.
Read MorePosted by Chris Wolski | Sep 8, 2021 | Molecular Diagnostic Analyzers |
Mission Bio has announced two key improvements to the core capabilities of its Tapestri Platform for hematologic oncology (heme-onc) research.
Read More